iShares Biotechnology ETF (NASDAQ:IBB) Shares Purchased by Valmark Advisers Inc.

Valmark Advisers Inc. boosted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 57.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,434 shares of the financial services provider’s stock after purchasing an additional 892 shares during the quarter. Valmark Advisers Inc.’s holdings in iShares Biotechnology ETF were worth $311,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. WealthCare Investment Partners LLC raised its stake in iShares Biotechnology ETF by 16.1% during the first quarter. WealthCare Investment Partners LLC now owns 12,012 shares of the financial services provider’s stock worth $1,408,000 after purchasing an additional 1,664 shares during the period. Garde Capital Inc. purchased a new position in iShares Biotechnology ETF during the first quarter worth approximately $36,000. Canton Hathaway LLC raised its stake in iShares Biotechnology ETF by 45.2% during the first quarter. Canton Hathaway LLC now owns 14,461 shares of the financial services provider’s stock worth $1,850,000 after purchasing an additional 4,500 shares during the period. Appleton Partners Inc. MA raised its stake in iShares Biotechnology ETF by 3.4% during the first quarter. Appleton Partners Inc. MA now owns 78,382 shares of the financial services provider’s stock worth $10,025,000 after purchasing an additional 2,579 shares during the period. Finally, Advisor Resource Council purchased a new position in iShares Biotechnology ETF during the first quarter worth approximately $257,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.6%

NASDAQ:IBB opened at $126.69 on Thursday. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $150.57. The firm’s 50 day moving average is $123.39 and its two-hundred day moving average is $129.66.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.